Euglena Co., Ltd. (TYO:2931)

Market Cap	66.42B
Revenue (ttm)	48.40B
Net Income (ttm)	-1.35B
Shares Out	136.39M
EPS (ttm)	-9.89
PE Ratio	n/a
Forward PE	240.49
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,216,000
Average Volume	1,662,935
Open	478.00
Previous Close	477.00
Day's Range	474.00 - 490.00
52-Week Range	381.00 - 550.00
Beta	-0.12
RSI	66.26
Earnings Date	Aug 8, 2025

About Accolade

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It also manufactures and sells foods and cosmetics using euglena. In addition, the company develops biofuel technology and environmental related technology for microalgae; and invests in biotechnology related business. Further, it produces, processes, and sells euglena, chlorella, watermelon, midori koji, etc.; and manufactures and sells organic fertilizer. Additionally, the company provides genome analysis services. Euglena Co., Ltd. was incorp...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2005
• Employees: 897
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2931

Financial Performance

In 2024, Euglena's revenue was 47.62 billion, an increase of 2.44% compared to the previous year's 46.48 billion. Losses were -650.00 million, -75.49% less than in 2023.